LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
63.36
-0.54 (-0.85%)
Dec 5, 2025, 4:00 PM EST - Market closed
LivaNova Employees
LivaNova had 2,900 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$465,159
Profits / Employee
-$74,995
Market Cap
3.46B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LIVN News
- 2 days ago - LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - Business Wire
- 3 days ago - LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - Business Wire
- 10 days ago - LivaNova to Present at Piper Sandler Healthcare Conference in December - Business Wire
- 11 days ago - LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - Business Wire
- 23 days ago - LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day - Business Wire
- 4 weeks ago - LivaNova PLC (LIVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance - Business Wire
- 6 weeks ago - LivaNova to Present at Wolfe Research Healthcare Conference in November - Business Wire